Is a complete BCBA/GILD research report available?

No complete published report is available for bcba/GILD (BCBA/GILD) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

BCBA/GILD (BCBA/GILD)

Buenos Aires Stock Exchange: BCBA/GILD · ARS

ARS 52,600

-875.00 (-1.6%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-30 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first BCBA/GILD analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	246.6T
Revenue (ttm)	41.1T
Net income (ttm)	12.7T
EPS (ttm)	ARS 10,158
P/E (trailing)	19.4x
Dividend	ARS 727 (1.36%)
Volume	955

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 41.1T
Net income (ttm): 12.7T
EPS (ttm): ARS 10,158
P/E (trailing): 19.4x
Market cap: 246.6T

All BCBA/GILD indicators

Market & fundamental data

Available fields

224

Groups with data

Currency

USD

Showing 224 of 224 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	AR
Employees	17,000
Employees Change	-600%
Employees Change Percent	-3.41
Enterprise value	ARS 263.5T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-07-30
Market cap	ARS 246.6T
Price	ARS 52,600
Price currency	ARS
Rev Per Employee	2,416,511,257.84x
Sic	2836
Symbol	bcba/GILD
Website	https://www.gilead.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.16%
EV Earnings	20.69x
EV/EBIT	14.69x
EV/EBITDA	11.81x
EV/FCF	18.64x
EV/Sales	5.92x
FCF yield	5.73%
P/B ratio	7.62x
P/E ratio	19.37x
P/S ratio	6x
PE Ratio10 Y	73.41x
PE Ratio3 Y	123.96x
PE Ratio5 Y	81.56x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	40.3%
EBITDA Margin	49.56%
FCF margin	31.78%
Gross margin	79.37%
Gross Profit	ARS 32.6T
Gross Profit Growth	4.91%
Gross Profit Growth Q	7.57%
Gross Profit Growth3 Y	3.3%
Gross Profit Growth5 Y	1.9%
Net Income	ARS 12.7T
Net Income Growth	54.5%
Net Income Growth Q	53.69%
Net Income Growth3 Y	18.18%
Net Income Growth5 Y	98.24%
Pretax Margin	36.07%
Profit Margin	30.99%
Profit Per Employee	ARS 748.9M
ROA	13.29
Roa5y	10.85
ROCE	25.61
ROE	43.36
Roe5y	24.33
ROIC	27.7
Roic5y	21.93

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	47.47%
Cagr3y	74.9%
Cagr5y	78.69%
Div CAGR3	101.36%
Div CAGR5	81.61%
EPS Growth	55.43
EPS Growth Q	54.81
EPS Growth3 Y	18.49
EPS Growth5 Y	98.31
FCF Growth	3.92%
FCF Growth Q	46.82%
FCF Growth3 Y	6.85%
FCF Growth5 Y	3.3%
OCF Growth	4.25%
OCF Growth Q	44.79%
OCF Growth10 Y	-5.37%
OCF Growth3 Y	6.38%
OCF Growth5 Y	2.95%
Revenue Growth	3.48x
Revenue Growth Q	4.4x
Revenue Growth3 Y	3.21x
Revenue Growth5 Y	3.07x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	ARS 0.53
Assets	ARS 77.7T
Cash	ARS 13.6T
Current Assets	ARS 27.9T
Current Liabilities	ARS 14.2T
Debt	ARS 30.6T
Debt EBITDA	ARS 1.49
Debt Equity	ARS 0.95
Debt FCF	ARS 2.17
Equity	ARS 32.4T
Interest Coverage	11.94
Liabilities	ARS 45.4T
Long Term Assets	ARS 49.9T
Long Term Liabilities	ARS 31.2T
Net Cash	ARS -15.7T
Net Cash By Market Cap	ARS -6.37
Net Debt EBITDA	ARS 0.77
Net Debt Equity	ARS 0.49
Net Debt FCF	ARS 1.11
Tangible Book Value	ARS -1.6T
Tangible Book Value Per Share	ARS -1,314

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.97
Inventory Turnover	3.34
Net Working Capital	ARS 913.2B
Quick ratio	1.54
Working Capital	ARS 12.7T
Working Capital Turnover	ARS 5,988

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.34%
Dividend Growth	39.23%
Dividend Growth Years	6%
Dividend per share	ARS 727
Dividend Years	8
Dividend Yield	1.36%
Ex Div Date	2026-06-12
Last Dividend	ARS 185
Payout Frequency	Quarterly
Payout Ratio	43.76%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	47.43%
200-day SMA	49,301.5
3Y total return	435.23%
50-day SMA	49,848
50-day SMA vs 200-day SMA	50over200
5Y total return	1,721.04%
All Time High	58,100
All Time High Change	-8.65%
All Time High Date	2026-02-11
All Time Low	656.5
All Time Low Change	7,984.54%
All Time Low Date	2019-04-22
ATR	1,556
Ch YTD	13.26
High	53,650
High52	58,100
High52 Date	2026-02-11
High52ch	-9.47%
Low	52,475
Low52	36,225
Low52 Date	2025-08-07
Low52ch	45.2%
Ma50ch	6.47%
Price vs 200-day SMA	7.65%
RSI	58.06
RSI Monthly	73.9
RSI Weekly	57.69
Sharpe ratio	1.26x
Sortino ratio	2.09
Total Return	1.7%
Tr YTD	14.36
Tr1m	8.18%
Tr1w	3.92%
Tr3m	9.89%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	ARS 16.6T
Operating Income Growth	9.44
Operating Income Growth Q	6.55
Operating Income Growth3 Y	5.45
Operating Income Growth5 Y	0.53
Operating margin	40.3

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,238,822,745%
Net Borrowing	-4,175,461,128,000
Shares Insiders	0.09%
Shares Institutions	89.78%
Shares Qo Q	0.08%
Shares Yo Y	-0.34%
Short Ratio	3.36

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	ARS 12.9T
Adjusted OCF	13,681,130,171,100
Average Volume	1,315.2x
Bv Per Share	26,156.4
CAPEX	ARS -795.8B
Ch1m	8.18
Ch1w	3.92
Ch1y	44.82
Ch3m	9.21
Ch3y	407.2
Ch5y	1,579.6
Ch6m	1.19
Change	-1.64%
Change From Open	-1.45
Close	53,475
Days Gap	-0.19
Depreciation Amortization	4,117,136,277,000
Dollar Volume	50,233,000
Earnings Date	2026-08-04
EBIT	ARS 16.6T
EBITDA	ARS 20.4T
EPS	ARS 10,158
F Score	8
FCF	ARS 14.1T
FCF EV Yield	5.36x
Financing CF	-11,822,994,244,600
Fiscal Year End	December
Founded	1,987
Goodwill	12,433,661,826,000
Graham Number	20541.86675
Graham Upside	-60.95
Income Tax	ARS 2.1T
Investing CF	-3,602,987,729,600
Is Primary Listing	0
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Lynch Fair Value	ARS 67,899
Lynch Upside	29.09
Ma150	50,504.3
Ma150ch	5.09%
Ma20	51,985.5
Ma20ch	2.1%
Net CF	-410,309,568,900
Next Earnings Date	2026-08-04
Open	53,375
P FCF Ratio	17.45
P FCF Ratio SBC	19.14
P OCF Ratio	16.52
P OCF Ratio SBC	18.02
Payment Date	2026-06-29
Position In Range	10.64
Ppne	8,431,679,742,000
Price Date	2026-07-29
Price EBITDA	ARS 12.11
Relative Volume	0.73x
Revenue	41,080,691,383,200x
SBC By Revenue	3.04x
Share Based Comp	1,247,506,871,100
Tax By Revenue	5.08x
Tax Rate	14.09%
Tr6m	2.18%
Volume	955
Z Score	4.51

BCBA/GILD (BCBA/GILD)

Coverage state: Market snapshot only — no published research

Generate the first BCBA/GILD analysis

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/GILD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/GILD indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on BCBA/GILD

Frequently asked questions